Method for treating rhinitis and sinusitis by rhamnolipids
The present invention is directed to methods for treating rhinitis or sinusitis in a subject. In one embodiment, the method comprises the steps of: identifying a subject in need thereof, and administering intranasally to the subject a formulation comprising an only active ingredient of an effective amount of rhamnolipid. In another embodiment, the method comprises the steps of: identifying a subject in need thereof, and administering intranasally to the subject a first active ingredient of an effective amount of a rhamnolipid and a second active ingredient of an effective amount of a corticosteroid, an antihistamine, a leukotriene antagonist, cromylin, an antibiotic, a sphingolipid, or a decongestant.
1. A method for treating a rhinitis or a sinusitis in a subject, comprising the steps of:
identifying a subject suffering from the rhinitis or the sinusitis; administering intranasally to the subject a formulation comprising a pharmaceutically acceptable carrier and a rhamnolipid as the only active ingredient in an effective amount, whereby the symptoms of rhinitis or sinusitis in the subject are reduced.
2. The method according to claim 1 , wherein said rhamnolipid is selected from the group consisting of: rhamnolipid 1, rhamnolipid 2, and the combination thereof.
3. The method according to claim 1 , wherein said effective amount is 0.005-10% (w/w).
4. The method according to claim 1 , wherein said effective amount is 0.02-5% (w/w).
5. The method according to claim 1 , wherein the rhinitis is allergic rhinitis, infectious rhinitis, non-allergic rhinitis, or mixed allergic and non-allergic rhinitis.
6. The method according to claim 5 , wherein the allergic rhinitis is perennial allergic rhinitis or seasonal allergic rhinitis.
7. The method according to claim 1 , wherein the method is for treating rhinitis.
8. The method according to claim 1 , wherein the method is for treating sinusitis.
9. The method according to claim 7 , wherein the method reduces one or more symptoms selected from the group consisting of nasal congestion, nasal discharge, sneezing, and itching of the nose and throat in the subject.
10. The method according to claim 8 , wherein the method reduces one or more symptoms selected from the group consisting of nasal congestion, rhinorrhea, sneezing, and nasal itching in the subject.